or Try an Advanced Search...

    Technical Analysis for ACHV - Achieve Life Sciences, Inc.

    Grade Last Price % Change Price Change
    F 4.31 -0.81% -0.04
    ACHV closed down 0.81 percent on Wednesday, November 20, 2024, on 68 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ACHV trend table...
    Date Alert Name Type % Chg
    Inside Day Range Contraction 0.00%
    Oversold Stochastic Weakness 0.00%
    Slingshot Bearish Bearish Swing Setup -0.81%
    Stochastic Buy Signal Bullish -0.81%
    Gapped Up Strength -0.81%
    Oversold Stochastic Weakness -0.81%
    NR7 Range Contraction 3.49%
    Lower Bollinger Band Walk Weakness 3.49%
    Below Lower BB Weakness 3.49%
    Down 3 Days in a Row Weakness 3.49%
    Older End-of-Day Signals for ACHV ...

       Recent Intraday Alerts

    Alert Time
    Gap Up Partially Closed 2 days ago
    Gapped Up (Partial) 2 days ago
    Rose Above Previous Day's High 2 days ago
    Rose Above Lower Bollinger Band 2 days ago
    1.5x Volume Pace 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ACHV Chart by TradingView
    Basic chart:

    Profile

    Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen

    Is ACHV a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
    Nov 11 ACHV: Commercialization in Focus
    Oct 24 Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024
    Oct 23 Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting
    Oct 16 Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline
    Oct 10 Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting
    Oct 1 Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs
    Sep 4 ACHV: New Skipper at the Helm
    Aug 19 ACHV: ORCA OL Enrolling at Rapid Pace
    Aug 14 Achieve Life Sciences, Inc. (ACHV) Q2 2024 Earnings Call Transcript
    See more ACHV news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.98
    52 Week Low 3.03
    Average Volume 111,051
    200-Day Moving Average 4.66
    50-Day Moving Average 4.72
    20-Day Moving Average 4.63
    10-Day Moving Average 4.47
    Average True Range 0.23
    RSI (14) 39.76
    ADX 17.92
    +DI 20.62
    -DI 27.36
    Chandelier Exit (Long, 3 ATRs) 4.61
    Chandelier Exit (Short, 3 ATRs) 4.82
    Upper Bollinger Bands 5.11
    Lower Bollinger Band 4.14
    Percent B (%b) 0.17
    BandWidth 20.89
    MACD Line -0.14
    MACD Signal Line -0.08
    MACD Histogram -0.0558
    Fundamentals Value
    Market Cap 91.12 Million
    Num Shares 21.2 Million
    EPS -2.02
    Price-to-Earnings (P/E) Ratio -2.13
    Price-to-Sales 0.00
    Price-to-Book 23.59
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.50
    Resistance 3 (R3) 4.50 4.44 4.47
    Resistance 2 (R2) 4.44 4.39 4.44 4.46
    Resistance 1 (R1) 4.37 4.36 4.34 4.37 4.45
    Pivot Point 4.31 4.31 4.30 4.31 4.31
    Support 1 (S1) 4.24 4.26 4.21 4.24 4.16
    Support 2 (S2) 4.18 4.23 4.18 4.15
    Support 3 (S3) 4.11 4.18 4.14
    Support 4 (S4) 4.11